Skip to content

Science

Everything filed under science — astronomy, chemistry, earth sciences, and 6 more.

4,243
shows
9
subcategories
6
new this week

Most subscribed

video · in science · refreshed hourly

Newest episodes

video · last seven days
  • Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi

    Revisiting - Book Review – Cybersecurity for Pharma 4.0: Regulatory Compliance and Audit Readiness

    Center of Excellence – Pharma 4.0 | Book Review | Book 2 of 9 In today's rapidly evolving pharmaceutical industry, digital transformation brings enormous opportunities—but also increasing cybersecurity, data integrity, and regulatory compliance challenges. Having secure digital systems is no longer enough. Pharmaceutical organizations must also be able to demonstrate that their systems, processes, and data are properly controlled, validated, traceable, and supported by reliable documentation. In this episode of Center of Excellence – Pharma 4.0, Dr. Jayant Joshi reviews Cybersecurity for Pharma 4.0: Regulatory Compliance and Audit Readiness, Book 2 of the nine-book Cybersecurity for Pharma 4.0 series, coauthored by Dr. Jayant Joshi and Umesh Naik. The book explores the critical intersection of pharmaceutical regulatory requirements, cybersecurity governance, data integrity, and audit preparedness. It highlights why compliance must be embedded into digital operations from the beginning rather than treated as a last-minute audit exercise. What does the book cover? The review explores three important chapters: Statutory and Regulatory Requirements for Digital Pharma Electronic records and electronic signatures. Computerized system compliance and GxP requirements. GMP, GDP, serialization, and quality risk management. Cybersecurity governance and data privacy. Building compliance into digital systems by design. Data Integrity and ALCOA+ in the Digital Supply Chain Maintaining attributable, legible, contemporaneous, original, and accurate records. Ensuring data remains complete, consistent, enduring, and available. Understanding data lifecycles, metadata, audit trails, timestamps, and access logs. Protecting data integrity across ERP, MES, LIMS, QMS, warehouse, transportation, and serialization systems. Addressing emerging challenges involving AI, IoT, cloud, and connected environments. Cybersecurity Documentation Required for Audit Readiness Cybersecurity policies and asset inventories. GxP impact assessments and cybersecurity risk records. Vulnerability management and incident response documentation. Supplier security assessments and access reviews. Backup, disaster recovery, and restoration testing. Change control and Corrective and Preventive Actions (CAPA). Practical documentation checklists for audit preparation. Why is this book important? Unlike generic IT cybersecurity resources, this volume specifically addresses the realities of regulated pharmaceutical environments. It connects cybersecurity controls with GxP processes, data integrity, quality management, and the evidence required to demonstrate regulatory compliance. It offers practical value to: CEOs and Board Members: Strengthening cybersecurity governance and accountability. Quality Assurance and Regulatory Teams: Improving compliance and audit preparedness. IT, OT and Cybersecurity Professionals: Understanding security documentation and control requirements. Manufacturing and Supply Chain Leaders: Protecting digital operations and maintaining trustworthy records. Validation Professionals: Supporting computerized system compliance and data integrity. One important takeaway from this book is that restoring a system after an outage does not automatically guarantee data integrity. Organizations must also demonstrate that records are complete, audit trails are preserved, reconciliations are performed, and quality impacts are properly assessed. The central message: Digital transformation earns trust when secure controls are backed by reliable evidence. Listen to this book review to understand how pharmaceutical organizations can move beyond implementing cybersecurity controls to establishing demonstrable, audit-ready compliance. Explore Cybersecurity for Pharma 4.0: Regulatory Compliance and Audit Readiness by Dr. Jayant Joshi and Umesh Naik, available on Amazon in Kindle and paperback formats, subject to regional availability. Follow, subscribe, and share the Center of Excellence – Pharma 4.0 podcast for more insights into pharmaceutical digital transformation, emerging technologies, cybersecurity, and the future of Pharma 4.0. Resources: Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB Book Series: Cybersecurity for Pharma 4.0 https://www.amazon.com/dp/B0HFW5988N Podcast: https://pharma4coe.podbean.com YouTube Channel: https://www.youtube.com/@COE-PHARMA4.0 Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/ Website: https://respa.com

    Today · 8 min· Video
  • Research To Practice | Oncology Videos

    Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics: Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00) ER-Positive Breast Cancer (5:01) HER2-Positive Breast Cancer (1:19:08) Triple-Negative Breast Cancer (1:48:54) CME information and select publications

    Yesterday · 2 hr 22 min· Video
  • Research To Practice | Oncology Videos

    Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics: Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00) ER-Positive Breast Cancer (5:01) HER2-Positive Breast Cancer (1:19:08) Triple-Negative Breast Cancer (1:48:54) CME information and select publications

    Yesterday · 2 hr 22 min· Video
  • Air Quality Matters

    From Build America to Smart Homes: Jason Wolfson on 25 Years of Residential Ventilation

    This week, we sit down with Jason Wolfson, President of AirCycler, who has spent over two decades at the centre of residential indoor air quality and energy efficiency standards in North America, to explore a question that fundamentally challenges how we think about home ventilation: What if the single biggest barrier to delivering healthy indoor air in homes isn't our lack of scientific knowledge or technology—but our complete failure to recognise that the past 25 years of ventilation strategy has been based on educated guesses using bedrooms and square footage. Key Topics Discussed: From Build America to Controlled Ventilation: The DOE's Build America program in 1995 under President Clinton was the epicentre of everything that followed. Homes were made airtight to save energy, reduce carbon and cut dependence on foreign oil. Insulation improved. Ducts were sealed. But then the problem became obvious. Humans are polluters. Homes had been naturally ventilated through leaks. That worked fine. You used to walk by a window and feel a draft in winter. But that was energy loss. When that energy loss was eliminated, controlled fresh air became essential. AirCycler developed the first commercial controller in 1999 that watched the thermostat and ensured minimum runtime on the blower so homes got a measured amount of air instead of relying on random leaks. The Bedroom and Square Footage Problem: For 25 years, ASHRAE 62.2 has determined ventilation rates based on a formula using bedrooms and square footage. Bedrooms plus one approximates occupancy. Square footage adds a factor for the size of the home. That formula has been the foundation of residential ventilation in the United States. But it is not a feedback system. It is a guess. Jason compares it to heating a home without being able to measure temperature. You would calculate the heat loss, install a furnace with double the capacity, and run it half the time. It might work on average, but you would be overheating or underheating constantly. That is exactly what has been happening with ventilation. Most of the time homes are overventilating, wasting energy. During high pollution events like cooking or large gatherings, homes are underventilating. The Only Question That Matters: Jason has one ask from the scientists at the IEA EBC Annex 101 conference. Tell me when to turn the ventilation on. That is it. What are the stressors to react to? What is the base rate to handle pollutants we cannot measure? Industry is already shipping products with responsive controls. They are reading peer reviewed literature and making engineering decisions. But they are not building scientists. They need guidance. If the academic and standards community does not adapt quickly enough, industry will outrun them. Local code officials will see what works in practice and adopt it into local codes. ASHRAE 62.2 and Annex 101 could become irrelevant. It happened in the computer industry in the 1980s when Intel outpaced IEEE on bus standards. It could happen here. GUEST: Jason Wolfson - https://www.linkedin.com/in/jason-wolfson-b3a5045/ AirCycler - https://www.aircycler.com/ IEA EBC Annex 101 - https://annex101.iea-ebc.org/ The Air Quality Matters Podcast in Partnership with Mann + Hummel https://www.mann-hummel.com/en.html Particles Plus https://particlesplus.com/ Eurovent (https://www.eurovent.eu/) - Aico (https://www.aico.co.uk/) - Lindab (https://www.lindab.ie/) - S&P UK (https://www.solerpalau.com/en-uk/) The One Take Podcast in Partnership with SafeTraces (https://www.safetraces.com/) - Inbiot (https://www.inbiot.es/?utm_campaign=simon&utm_source=airqualitymatters&utm_medium=podcast) - Farmwood (https://farmwood.co.uk/) - iE Electronics (https://www.eielectronics.ie/) and iAir Group (https://iair-group.com/) Zehnder https://www.zehndergroup.com/en Charity Partner - https://www.saferairproject.org/

    Yesterday · 1 hr 22 min

Video in Science63